Current strategies to prevent stroke in atrial fibrillation may require a closer look, according to two new studies.
Microchip’s LAN866x 10BASE-T1S endpoint devices use the Remote Control Protocol (RCP) to extend Ethernet connectivity in ...
In the ongoing Phase 2 AMPLIFY-7P study evaluating ELI-002 7P in patients with pancreatic ductal adenocarcinoma ('PDAC”), ...
17hon MSN
PDS Biotech outlines trial protocol amendment for accelerated PFS endpoint in HPV16-positive cancer
Q3 2025 Management View CEO Frank Bedu-Addo provided an update on advancing PDS0101 (Versamune HPV) in HPV16-positive recurrent and/or metastatic head and neck cancer, highlighting the completion of ...
The ARTISTRY-1 Phase III trial demonstrated that a single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg maintains viral suppression and simplifies therapy for people living with HIV, ...
Novartis (NVS) (OTCPK:NVSEF) has announced that its next-generation malaria treatment, KLU156 (GanLum), developed with Swiss ...
TD Cowen Immunology and Inflammation Summit November 13, 2025 4:30 PM ESTCompany ParticipantsDiana GallagherConference ...
CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise ...
The trial enrolled 553 children aged 5 -17 years with moderate to severe birch pollen-induced ARC, with or without asthma, across 64 sites in 12 European countries and assessed the efficacy and safety ...
Detalimogene voraplasmid (detalimogene; formerly EG-70) demonstrated promising responses in patients with high-risk Bacillus ...
Cybereason, a leading global cybersecurity company, today announced the launch of a new Vulnerability Management product, a ...
A year of escalating social-engineering attacks has produced one of the most efficient infection chains observed to date. Known as ClickFix, this method requires only that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback